Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Gustoeson Sep 14, 2017 12:46am
123 Views
Post# 26693741

RE:RE:RE:RE:New Q3 Presentation

RE:RE:RE:RE:New Q3 Presentation
Gustoes wrote:
goldn1 wrote:
Bencro:

You do more research on this stock than anyone I know... Typically, when you see a company that has the potential to cure cancer and now has done it 3 times in humans, you see a lot of speculative money come in as the potential of the stock is tremendous. I know I continue to buy on dips and holda big position and I am sure others do as well. But most of the buying seems to come from stockhouse members and no new investors, or none tha are substancial.

I am going to ask you a question I am unable to answer: Why can't TLT get any traction on its share price???

If TLT can really take this to market, the .54 warrants and an October PP shouldn't stop the price from going up, as long as they have the cure. Thanks in advance...


G1


Here's all you need to know about why TLT can't take off.
It's controlled by traders which kills market cap appreciation which kills capital raising efforts and forces heavier than normal dilution with shitty terms which further beats down the sp. It's a vicious cycle and the Venture just needs to die and TLT needs to get off it.

https://www.equedia.com/why-the-tsx-venture-is-failing/
https://www.equedia.com/how-to-fix-tsx-venture-problems/





This is why Mr. Frost is our friend. Shitty terms and financing aside, it is what it is, at least have a potentially valuable partner to get off the ground. Once that occurs, new doors open.


Manipulation on the Canadian Market

I have witnessed trades for many stocks where you can clearly see the manipulative efforts of small block sell orders coming through, that appear to be intentionally forcing share price down. Those with real-time Level II will be able to see this activity all day long. Much of this activity runs through the houses of Canada’s biggest banks, and it almost always forces the price of stocks down to a point where liquidity and buy orders have completely dried up and there is no more stock floating around in the system to short.

With the removal of the uptick rule, firms are now shorting at will and destroying companies for small profits. Institutions have many advantages that we don’t. They can short stock and have a fairly lengthy period before they have to replace that stock, should their shorts need to be covered. Even if their shorts need to be covered in a short time frame, they can extend that time frame by borrowing stock owned by their clients.

Too big too fail is sadly a very real scenario. As smaller institutions dry up, investors will transfer over to the bigger guys who will then control more money.

Considering that more than 50% of the world’s financing for resource projects stems from Canada, with a third coming form the TSX and the Venture, the resource sector is not looking very bright.

But don’t think its over. Not for one second.

Foreign Equity Opportunity

Companies are having extreme troubles funding through public vehicles because that money has dried up due to over manipulation and regulation (for now.) But that doesn’t mean capital isn’t available.

As a matter of fact, capital is abundant – especially in foreign countries.

Private equity is growing and foreign capital is looking for a place to call home. Foreign investors not only have an abundant wealth of capital, but they’re looking to deploy it.

I know this because I work with a few very smart individuals to help fund good projects through strategic, private equity, sovereign wealth fund and state-owned enterprise buyers.

Please don’t hesitate to send me information if you’re a company that needs help.

Companies who are smart and have great assets should start looking elsewhere for money.

Until next time,

Ivan Lo

The Equedia Letter

Bullboard Posts